239 related articles for article (PubMed ID: 7685989)
1. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
Koutsilieris M; Frenette G; Lazure C; Lehoux JG; Govindan MV; Polychronakos C
Anticancer Res; 1993; 13(2):481-6. PubMed ID: 7685989
[TBL] [Abstract][Full Text] [Related]
2. Proteinolytic activity against IGF-binding proteins involved in the paracrine interactions between prostate adenocarcinoma cells and osteoblasts.
Koutsilieris M; Polychronakos C
Anticancer Res; 1992; 12(3):905-10. PubMed ID: 1377896
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton.
Reyes-Moreno C; Koutsilieris M
Clin Exp Metastasis; 1997 May; 15(3):205-17. PubMed ID: 9174122
[TBL] [Abstract][Full Text] [Related]
4. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
[TBL] [Abstract][Full Text] [Related]
5. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).
Angelloz-Nicoud P; Binoux M
Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299
[TBL] [Abstract][Full Text] [Related]
6. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
Lalou C; Silve C; Rosato R; Segovia B; Binoux M
Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases.
Angelloz-Nicoud P; Harel L; Binoux M
Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
11. [Interactions of insulin-like growth factors (IGF) and their binding proteins with the plasminogen/plasmin activator system in cultured osteoblasts].
Lalou C; Silve C; Segovia B; Binoux M
Ann Endocrinol (Paris); 1994; 55(2):103-7. PubMed ID: 7802427
[TBL] [Abstract][Full Text] [Related]
12. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex.
Campbell PG; Novak JF; Yanosick TB; McMaster JH
Endocrinology; 1992 Mar; 130(3):1401-12. PubMed ID: 1371448
[TBL] [Abstract][Full Text] [Related]
15. Alterations in insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis in transformed osteoblastic cells.
Durham SK; Riggs BL; Harris SA; Conover CA
Endocrinology; 1995 Apr; 136(4):1374-80. PubMed ID: 7534697
[TBL] [Abstract][Full Text] [Related]
16. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.
Cohen P; Peehl DM; Lamson G; Rosenfeld RG
J Clin Endocrinol Metab; 1991 Aug; 73(2):401-7. PubMed ID: 1713219
[TBL] [Abstract][Full Text] [Related]
18. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
Waghray A; Webber MM
Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta.
Durham SK; Riggs BL; Conover CA
J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
